Published in Eur Arch Otorhinolaryngol on July 26, 2007
Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. Int J Epidemiol (2015) 0.91
Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol (2012) 0.81
HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients. Oncol Lett (2012) 0.77
Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin. Tumour Biol (2014) 0.77
LOH-profiling by SNP-mapping in a case of multifocal head and neck cancer. World J Clin Oncol (2012) 0.75
Oral cancer among patients under the age of 35 years. J Postgrad Med (2002) 1.54
Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.40
Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head Neck (1998) 1.35
Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck (1994) 1.21
Cancer of the tongue in patients less than forty. Head Neck (2000) 1.10
Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol (2003) 1.09
Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer (2002) 1.09
Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol (1998) 1.08
Marijuana smoking--possible cause of head and neck carcinoma in young patients. Otolaryngol Head Neck Surg (1986) 1.08
Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg (1996) 1.07
Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst (1996) 1.04
Squamous cell carcinoma of the tongue among young Indian adults. Neoplasia (2001) 1.04
Squamous cell carcinoma of the oral cavity, pharynx, and larynx in young adults. Laryngoscope (1985) 1.03
CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res (2005) 1.02
Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck (2000) 1.02
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer (2001) 0.99
Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett (1993) 0.98
Reduced DNA repair capacity in laryngeal cancer subjects. A comparison of phenotypic and genotypic results. Adv Otorhinolaryngol (2005) 0.94
The implication of tobacco use in the young adult with head and neck cancer. Cancer (1988) 0.93
Survival in patients under 45 years with squamous cell carcinoma of the oral tongue. Int J Oral Maxillofac Surg (2003) 0.90
Head and neck cancer in a young age group: high incidence in black patients. Head Neck Surg (1983) 0.90
Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients. Br J Cancer (2001) 0.88
Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Arch Otolaryngol Head Neck Surg (1997) 0.88
Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA (1989) 0.87
A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope (1999) 0.87
p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years. Oral Oncol (1999) 0.86
Squamous cell carcinoma of the head and neck in patients 40 years of age and younger. Laryngoscope (1988) 0.86
Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet Cytogenet (1985) 0.86
Single cell gel electrophoresis on peripheral blood leukocytes of patients with oral squamous cell carcinoma. J Oral Pathol Med (1997) 0.86
Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncol (1999) 0.84
High frequency of microsatellite instability in young patients with head-and-neck squamous-cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 AND hMSH2. Int J Cancer (2001) 0.83
Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis. J Med Genet (2004) 0.81
Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection. Arch Otolaryngol Head Neck Surg (1996) 0.80
An immunologic profile of young adults with head and neck cancer. Cancer (1989) 0.80
Squamous cell carcinoma of the head and neck in patients under 40 years of age. Arch Otolaryngol (1985) 0.79
Head and neck cancer in the young: a prognostic conundrum? J Laryngol Otol (1990) 0.79
Outcome differences in younger and older patients with laryngeal cancer: a retrospective case-control study. Am J Otolaryngol (2000) 0.78
Relation between age and head and neck cancer recurrence after surgery: a multivariate analysis. Otolaryngol Head Neck Surg (1995) 0.78
Glutathione S transferase M1 andT1 genotypes and susceptibility to smoking related larynx cancer. Biomarkers (1998) 0.77
Mutagen sensitivity of patients with cancer at different sites of the head and neck. Mutagenesis (2005) 0.77
Higher glutathione transferase GSTM1 0/0 genotype frequency in young thyroid carcinoma patients. Curr Med Res Opin (2003) 0.76
Non-random distribution of chromatid breaks in lymphocytes of laryngeal squamous cell carcinoma patients. Oncol Rep (2004) 0.76
[Clinical and histopathological analysis of squamous cell carcinoma of the head and neck in young adults]. Otolaryngol Pol (2007) 0.76
Carcinoma of the hypopharynx and cervical esophagus in young adults. Ann Otol Rhinol Laryngol (2000) 0.75
Association of GST genotypes with age of onset and lymph node metastasis in oral squamous cell carcinoma. J Oral Pathol Med (2005) 0.75
[The role of exogenous and epidemiological factors in etiology of squamous cell carcinoma of the head and neck in young adults]. Otolaryngol Pol (2007) 0.75
[Carcinomas of the upper aerodigestive tract before age 40 (excluding children). Apropos of 100 cases]. Ann Otolaryngol Chir Cervicofac (1987) 0.75
[Cancer of the larynx in patients under 40 years of age]. Otolaryngol Pol (1990) 0.75
[Marijuana and malignant tumors of the upper aerodigestive tract in young patients. On the risk assessment of marijuana]. Laryngorhinootologie (1993) 0.75
[Individual sensitivity to the mutagenic agents in patients with larynx cancer]. Otolaryngol Pol (2004) 0.75
Squamous cell carcinoma of the tonsil in young adults. Cancer (1977) 0.75
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet (2011) 11.28
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res (2009) 1.85
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res (2009) 1.53
Algorithm changes in treatment of submandibular gland sialolithiasis. Eur Arch Otorhinolaryngol (2013) 1.40
Inflammation, cardiometabolic markers and functional changes in a randomized controlled trial of a 12-month exercise program for prostate cancer men. Pol Arch Med Wewn (2017) 1.39
The genetics of keratoconus. Middle East Afr J Ophthalmol (2011) 1.14
Consistent chromosome abnormalities identify novel polymicrogyria loci in 1p36.3, 2p16.1-p23.1, 4q21.21-q22.1, 6q26-q27, and 21q2. Am J Med Genet A (2008) 1.12
Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function. Eur J Hum Genet (2011) 1.08
High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. Genes Chromosomes Cancer (2010) 1.06
CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res (2005) 1.02
Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian, and Polish patients. Hum Mutat (2002) 1.01
Total skin electron irradiation techniques: a review. Postepy Dermatol Alergol (2013) 0.99
Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region. Cancer Lett (2004) 0.98
Novel mutation and three other sequence variants segregating with phenotype at keratoconus 13q32 susceptibility locus. Eur J Hum Genet (2011) 0.98
Frequent chromosomal gains in recurrent juvenile nasopharyngeal angiofibroma. Cancer Genet Cytogenet (2007) 0.98
Further delineation of nonhomologous-based recombination and evidence for subtelomeric segmental duplications in 1p36 rearrangements. Hum Genet (2009) 0.98
Deletions and duplications of developmental pathway genes in 5q31 contribute to abnormal phenotypes. Am J Med Genet A (2011) 0.97
Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci (2012) 0.94
The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck. Cancer Lett (2005) 0.94
Reduced DNA repair capacity in laryngeal cancer subjects. A comparison of phenotypic and genotypic results. Adv Otorhinolaryngol (2005) 0.94
Sialoendoscopy and combined approach for the management of salivary gland stones. Eur Arch Otorhinolaryngol (2012) 0.93
Identification of a novel polymorphism--the duplication of the NPHP1 (nephronophthisis 1) gene. Am J Med Genet A (2006) 0.93
Mutation analysis of mitochondrial 12S rRNA gene in Polish patients with non-syndromic and aminoglycoside-induced hearing loss. Biochem Biophys Res Commun (2010) 0.91
89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma. Nucl Med Commun (2007) 0.90
Oxidative DNA base modifications and polycyclic aromatic hydrocarbon DNA adducts in squamous cell carcinoma of larynx. Free Radic Res (2003) 0.89
An evaluation of the preservation of residual hearing with the Nucleus Contour Advance electrode. Acta Otolaryngol (2009) 0.89
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol (2011) 0.89
[The otologic manifestation of Wegener's granulomatosis--review of contemporary achievements in diagnostics and treatment]. Otolaryngol Pol (2012) 0.89
Monosomy 1p36 breakpoints indicate repetitive DNA sequence elements may be involved in generating and/or stabilizing some terminal deletions. Chromosome Res (2004) 0.89
The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. Toxicol Lett (2006) 0.89
A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene (2013) 0.89
The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival. Tumour Biol (2014) 0.88
Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7). Cancer Genet Cytogenet (2010) 0.88
Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization. Mol Biol Rep (2013) 0.88
Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells. Pharmacol Rep (2007) 0.87
Stenoses of the salivary ducts-sialendoscopy based diagnosis and treatment. Br J Oral Maxillofac Surg (2012) 0.87
Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol (2005) 0.87
Screening of the general Polish population for deafness-associated mutations in mitochondrial 12S rRNA and tRNA Ser(UCN) genes. Genet Test Mol Biomarkers (2009) 0.86
Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma. Eur Arch Otorhinolaryngol (2006) 0.86
[DHR brachytherapy as palliative treatment of advanced lung cancer in patients treated previously on another cancer]. Pol Arch Med Wewn (2003) 0.86
Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg (2004) 0.86
Substitution at IL1RN and deletion at SLC4A11 segregating with phenotype in familial keratoconus. Invest Ophthalmol Vis Sci (2013) 0.86
High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers. Brachytherapy (2011) 0.85
Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene. Cancer Biomark (2011) 0.85
Stent-graft treatment of extracranial internal carotid artery aneurysm. Eur Arch Otorhinolaryngol (2005) 0.85
Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. J Oral Pathol Med (2014) 0.85
Genotoxicity of the volatile anaesthetic desflurane in human lymphocytes in vitro, established by comet assay. J Appl Genet (2005) 0.85
The Cys326 allele of the 8-oxoguanine DNA N-glycosylase 1 gene as a risk factor in smoking- and drinking-associated larynx cancer. Tohoku J Exp Med (2009) 0.85
Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines. Cancer Genet Cytogenet (2008) 0.84
EGFR gene mutations in patients with adenosquamous lung carcinoma. Asia Pac J Clin Oncol (2014) 0.84
Rearrangements involving the 13q chromosome arm committed to the progression of laryngeal squamous cell carcinoma. Cancer Genet Cytogenet (2002) 0.84
[Sialendoscopy as a non-invasive treatment method of sialolithiasis and non-inflammatory processes causing salivary gland swelling]. Otolaryngol Pol (2011) 0.84
Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer. Mol Biol Rep (2009) 0.83
Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma. Int J Oncol (2011) 0.83
Frequent gene hypermethylation in laryngeal cancer cell lines and the resistance to demethylation induction by plant polyphenols. Toxicol In Vitro (2010) 0.82
IGF-1 gene polymorphisms in Polish families with high-grade myopia. Mol Vis (2011) 0.82
[Deep lobe of parotid gland tumors]. Otolaryngol Pol (2006) 0.81
Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients. Oral Oncol (2008) 0.81
Aberrations of 11q13 in laryngeal squamous cell lines and their prognostic significance. Cancer Genet Cytogenet (2005) 0.81
Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus. Mol Vis (2011) 0.81
microRNAs are important players in head and neck carcinoma: a review. Crit Rev Oncol Hematol (2013) 0.81
Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1. J Clin Endocrinol Metab (2008) 0.81
The impact of prelaryngeal node metastases on early glottic cancer treatment results. Eur Arch Otorhinolaryngol (2011) 0.81
The presence of facial nerve weakness on diagnosis of a parotid gland malignant process. Eur Arch Otorhinolaryngol (2011) 0.80
Stensen's duct injuries: the role of sialendoscopy and adjuvant botulinum toxin injection. Wideochir Inne Tech Maloinwazyjne (2013) 0.80
Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck. J Appl Genet (2011) 0.80
New insight into Baha® implant stability measurements: observations on resonance frequency analysis results. Otol Neurotol (2013) 0.80
Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol (2006) 0.80
Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients. Mol Biol Rep (2009) 0.80
[Tinnitus in systemic diseases]. Otolaryngol Pol (2002) 0.80
Clinical evaluation of cochlear implant sound coding taking into account conjectural masking functions, MP3000™. Cochlear Implants Int (2011) 0.80
The influence of environmental exposure to complex mixtures including PAHs and lead on genotoxic effects in children living in Upper Silesia, Poland. Mutagenesis (2006) 0.79
Comparison of rehabilitation results in deaf patients with and without genetically related hearing loss. Cochlear Implants Int (2008) 0.79
[Malignant tumors of the nose and paranasal sinuses in the years 1992-2001]. Otolaryngol Pol (2006) 0.79
Simple technique for RNA purification from mouse inner ear hair cells. Mol Biol Rep (2012) 0.79
[Unilateral tinnitus--diagnostics and treatment]. Otolaryngol Pol (2002) 0.79
[A proposal for the classification of chronic sialadenitis of the major salivary glands with current diagnostic and treatment schedule]. Otolaryngol Pol (2011) 0.79
Analysis of chromosome aberrations in cell lines derived from laryngeal cancer in relation to tumor progression. Eur Arch Otorhinolaryngol (2002) 0.79
[Microscopy and endoscopy of the cerebellopontine angle in the retrosigmoid approach]. Otolaryngol Pol (2004) 0.79
[Analysis of molecular background of hereditary haemorrhagic telangiectasia--Rendu-Osler-Weber disease--preliminary results]. Otolaryngol Pol (2008) 0.79
Recommendations for the diagnosis of human papilloma virus (HPV) high and low risk in the prevention and treatment of diseases of the oral cavity, pharynx and larynx. Guide of experts PTORL and KIDL. Otolaryngol Pol (2013) 0.79